Bing-Hua Jiang

7PUBLICATIONS
15CO-AUTHORS
Metabolic medicineMolecular targetsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2024
HDAC1 and FOXK1 mediate EGFR-TKI resistance of non-small cell lung cancer through miR-33a silencing.

Jie Liu, Wei Wang, Kunkun Wang

|Jun 24, 2022
ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.

David C Stieg, Yifang Wang, Ling-Zhi Liu

|Feb 15, 2022
miR-196a Upregulation Contributes to Gefitinib Resistance through Inhibiting GLTP Expression.

Bing-Jie Liu, Fang-Fang Li, Yun-Xia Xie

|Oct 19, 2021
TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination.

Cheng-Fei Jiang, Yun-Xia Xie, Ying-Chen Qian

Pageof 2